Several adjunctive variables, not investigated in the present study, such as the level of stromal Lymphocyte Tumor Infiltration (sTIL) and PIK3CA mutations, EGFR or PTEN expression, along with distinct intrinsic molecularly-defined subtypes, may have influenced outcomes [16–21]. This evidence concerns the gene PTEN and neoplasm.